top of page
watsonpeter272

Why Life Sciences Companies Avoid Social Media Engagement And How Can It Be Countered?

A recent boom in social media platforms has profusely dispersed healthcare information among a significant global population. In other words, social media does influence people’s healthcare decisions.

It is sensible when you realize a staggering percent of healthcare professionals have social media profiles!

Where major global brands are ensuring consistent presence on social media, life sciences companies are holding themselves back.


But what is the reason?

The reason is simple yet crucial, still needs to be countered

The most important reason is compliance and regulatory concerns!

Due to compliance and regulatory concerns, many life sciences companies are not engaging in social media productively. In other words, the giants in the life sciences industry prefer staying at a one-arm distance from the most glorious social media platform that has touched every domain and industry globally.

But, even if a life sciences company steps forward to engage more on the social media platform, it may face many potential risks.


Several downright risks are stated below.

Content And Employee Engagement Risk

Resource Intensive

Suboptimal Content Review Process

Varying Reviews for Type of Content

Costs and Complexity

More Creative Work Than Posting on Social Media

Not being able to engage with social channels to maximum advantage is disappointing since today’s world needs their engagement more than ever.


There is a real commercial risk for firms that don’t engage with their online audiences. The recent pandemic emphasizes the importance of communicating with these external audiences through the most popular marketing channel — social media. In-person meetings with doctors are reduced and patients are consuming content on social media everyday.


So, life sciences must take a more holistic view of social media channels when defining their overall communications strategy, and it somewhere seems plausible.


The Solution- Becoming Socially Active While Being Compliant!


The solution is to opt for a compliant social media amplification and publishing platform for life sciences companies that are entirely safe to use, e.g., MarketBeam.


MarketBeam is an AI-driven employee advocacy tools that publishes, amplifies, measures, and tracks social media content while keeping your industry compliance intact.

Companies should be able to eliminate system, site, and country silos and streamline end-to-end processes across commercial, medical, clinical, regulatory, quality, and safety.

With such platforms, life science firms can also streamline the process of creating social media posts, gaining Medical, Legal & Regulatory (MLR) approvals, and publishing content to social networks using a single integrated workflow. MarketBeam integrates with Veeva Vault PromoMats if the MLR process is maintained within Veeva.


Such a tool can be an excellent relief for life science companies where the costs are not exceeding a reasonable bracket while being active on social media.

Employees can share the approved content on social media without erring or putting compliance at stake. Hence, firms can eliminate social media risks by proactively providing employees with a fun and convenient way to share compliant company-generated content.


Leveraging social networks to deliver engaging content will become increasingly essential, and staff has an important part to play in sharing these communications widely.


The Bottom Line!

Life Science companies must navigate the complexities of managing their social media presence so that they can engage key stakeholders.

It is a critical step to engage with the public on social media to get an insight into user behavior that further assists their breakthroughs in the life sciences arena.


13 views0 comments

Recent Posts

See All

Comentários


bottom of page